Showing results (311-320 of 322) with videos related to
Sort By:
Pageof 33
Nature Communications|July 1, 2025
An mRNA vaccine encoding five conserved Group A Streptococcus antigensNichaela Harbison-Price, Ismail Sebina, Rhiannon A Bolton, et al.Cell Host & Microbe|June 13, 2014
The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine designNina M van Sorge, Jason N Cole, Kirsten Kuipers, et al.Nature Microbiology|April 23, 2026
Emergence of distinct Streptococcus pyogenes emm1 and emm12 lineages in ChinaYuanhai You, Dingle Yu, Chao Yang, et al.The Lancet. Microbe|May 11, 2022
A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding studyJoshua Osowicki, Kristy I Azzopardi, Loraine Fabri, et al.Nature Communications|August 5, 2014
Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracyclineViolette Da Cunha, Mark R Davies, Pierre-Emmanuel Douarre, et al.Nature Communications|February 24, 2023
Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeAMark R Davies, Nadia Keller, Stephan Brouwer, et al.The Journal of Infectious Diseases|May 23, 2012
Molecular characterization of the 2011 Hong Kong scarlet fever outbreakHerman Tse, Jessie Y J Bao, Mark R Davies, et al.Nature Communications|March 19, 2023
Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteriaAndre Mu, William P Klare, Sarah L Baines, et al.Nature Genetics|May 29, 2019
Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomicsMark R Davies, Liam McIntyre, Ankur Mutreja, et al.Nature Genetics|July 21, 2019
Author Correction: Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomicsMark R Davies, Liam McIntyre, Ankur Mutreja, et al.Pageof 33